180 WEALTH ADVISORS, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 281 filers reported holding GW PHARMACEUTICALS PLC in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
180 WEALTH ADVISORS, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2019$253,000
+2.4%
1,383
-3.3%
0.12%0.0%
Q4 2018$247,0000.0%1,4300.0%0.12%
+0.9%
Q3 2018$247,000
-7.5%
1,430
-25.4%
0.11%
-13.6%
Q2 2018$267,000
+24.8%
1,916
+18.1%
0.13%
+21.1%
Q4 2017$214,0001,6220.11%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2018
NameSharesValueWeighting ↓
Lamond Capital Partners LLC 134,230$9,085,0005.95%
VHCP Management, LLC 311,853$21,106,0005.81%
Iguana Healthcare Management, LLC 60,000$4,061,0001.96%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 366,187$24,784,0000.95%
ACUTA CAPITAL PARTNERS, LLC 20,000$1,354,0000.92%
United Asset Strategies, Inc. 14,278$966,0000.41%
PRUDENTIAL PLC 823,408$55,728,0000.24%
Rock Springs Capital Management LP 28,000$1,895,0000.22%
CLOUGH CAPITAL PARTNERS L P 84,600$5,726,0000.20%
Eventide Asset Management 25,000$1,692,0000.18%
View complete list of GW PHARMACEUTICALS PLC shareholders